SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlaa Emara
About this trial
To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Eligibility criteria
Qualifiers
Indication for tonsillectomy according to the applicable clinical guideline.
Male or female patients aged 18 years or older.
Ability to understand the study information and provide written informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Suprathel 250
- Comparator
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Alaa Emara
Lead sponsor
Cairo University
Sponsor institution
Source ClinicalTrials.gov